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Abstract
Visceral leishmaniasis (VL) was observed in children in Bakool region, Somalia, an area where VL has
not been reported before. We describe the extent of the problem in this war- and famine-stricken area. A
retrospective analysis was done of all cases admitted to a VL treatment centre between July 2000 and
August 2001. Patients with longstanding fever, splenomegaly and a positive direct agglutination test
(DAT; titre . 1:3200) were treated as suspected VL cases. A rapid epidemiological and entomological
assessment was performed in the area. Species identification was attempted from blood samples by
polymerase chain reaction–restriction fragment length polymorphism analysis of cysteine proteinase B
genes. In 1 year, 230 serologically-positive cases were diagnosed as VL, and response to therapy was
good in 91.6% of the 225 treated with sodium stibogluconate. Parasitological confirmation was
attempted and obtained in 2 cases. Parasites were found to be most similar to Sudanese and Ethiopian
reference strains of the Leishmania donovani complex. In a serological survey of 161 healthy displaced
persons, 15% were positive by the leishmanin skin test and 3 (2%) were positive by the DAT. The
sandfly captures showed Phlebotomus martini and P. vansomerenae. VL seems to be a longstanding and
serious health problem in Bakool region. Food insecurity might have contributed to the emergence and
detection of VL in this area.
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Introduction
In July 2000, a visceral leishmaniasis (VL) outbreak
occurred in the north-east of Kenya and the south of
Somalia as well as in the Somali refugee population
(Boussery et al., 2001) (Fig. 1). At that time, Me ´decins
sans Frontie `res (MSF) ran a feeding programme for
severely malnourished children in Huddur, Somalia, in
the drought-affected region of Bakool. As several mal-
nourished children did not improve after receiving
therapeutic feeding and care, first tuberculosis (TB)
and later VL was suspected. Finger-prick blood sam-
ples on filter-paper from 8 non-responding children in
the feeding programme were found positive by the
direct agglutination test (DAT) for VL carried out at
the Institute of Tropical Medicine (ITM), Antwerp,
Belgium in July 2000. The relief programme in Huddur
has no laboratory facilities and subsequently, arrange-
ments were made to send filter-paper blood samples
from children with suspected VL to an MSF laboratory
in Kenya. Children with clinical signs and symptoms of
VL who were DAT-positive were, thereafter, treated
with a standard antimonial regimen and responded
well.
A rapid population assessment in the Bakool area in
August 2000, showed that 5% of 2221 persons exam-
ined had clinical signs and symptoms suggestive of VL,
but no further confirmation was attempted at that time.
The clinical syndrome of VL seemed to be familiar to
the people and was perceived as an important contribu-
tor to child mortality (MSF, unpublished report).
However, no case reports about VL in Bakool and
Gedo regions were found in the medical literature prior
to 2000. Before the civil war (ongoing since 1991),
sporadic cases of VL were reported from several areas
in Somalia: Penso (1934) and Moise (1955) reported
VL cases from the coastal areas in the south of the
country; Baruffa (1965) reported 12 parasitologically-
proven cases from Middle Shebelle region; Shiddo et al.
(1995) described a VL-endemic area along the Shebelle
river in the south of Somalia; and Woolhead (1995)
wrote a case report about 1 VL case diagnosed in
Baidoa, Bay region, and warned of a potential increase
in incidence related to the war and famine. MSF has
supported the hospital in Kismayo since the early
1990s and claims that 38 VL cases were diagnosed and
treated in Kismayo in 1995 and 1996. These patients
came from Lower Juba region (MSF, unpublished
report). We present the available clinical and epidemio-
logical data on the VL problem in the Bakool region of
Somalia, where VL has not been reported before.
Methods
We reviewed all available clinical and epidemio-
logical data from the period July 2000 to August 2001.
In the clinical case series, we included all records of
DAT-positive (titre . 1:3200) clinically suspected
cases admitted between July 2000 and August 2001.
Between July 2000 and March 2001, any patient pre-
senting to the MSF centre in Huddur with a history of
fever for >1 month and splenomegaly and/or wasting
was first treated for malaria and any infection. If there
was no significant improvement and the patient still
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Fig. 1. Localization of recent outbreaks (2000–01) of visceral
leishmaniasis (VL) and known endemic areas (pre-2000) in
the Horn of Africa.had fever at 2-week follow-up, a blood sample was
taken on filter-paper to perform a DAT. If the DAT
was positive, antimonial treatment was started. From
the beginning of April 2001, the DAT was done at first
presentation, without waiting for the result of malarial
or other antimicrobial treatment. The standard treat-
ment used was sodium stibogluconate (SSG; produced
by Albert David Ltd, Calcutta, India) as a daily i.m.
injection at a dosage of 20 mg=kg=bodyweight for 30 d.
Cure was defined as ‘no fever in the last week of the
treatment, some reduction of the spleen size and im-
proved general wellbeing’. If there were still records of
fever in the last week of the 30-d regimen, the treat-
ment was extended for 14 d.
An entomological assessment was done in March,
May, June, and August 2001. Sandflies were captured
at night on oily papers in the ventilation shafts of
termite hills in and around Huddur. The sandflies were
collected from the oily papers, washed, and preserved
on the spot. They were analysed at the Ministry of
Health laboratories in Nairobi, Kenya (courtesy of Dr
D. Sang).
The epidemiological assessment consisted of exhaus-
tive screening with the DAT and leishmanin skin test
(LST) of all inhabitants of a camp of displaced persons
from Bakool region. These people left their home areas
because of deteriorating food security and had been
settled for 4 years on the outskirts of Huddur town, the
regional capital. As no Somalian government health
authorities were available to seek ethical clearance,
approval for the conduct of the survey was requested
from local authorities and the MSF headquarters in
Brussels, Belgium. Informed consent was obtained on
an individual basis from the subject or from his/her
carer, prior to enrolment. On the condition they gave
informed consent, they had an LST and 1 drop of
finger-prick blood was collected on Whatmann 2MM
filter-paper for the DAT. The leishmanin reagent
(Leishmania infantum, 3106 promastigotes per millili-
tre, prepared and donated by Dr M. Gramiccia, Labor-
atorio di Parassitologia, Istituto Superiore di Sanita `,
Rome, Italy) was injected intradermally in a quantity of
0.1 mL into the volar part of the left forearm. The
injection site was examined after 48 h and induration
was read according the technique recommended by
WHO (1984): by applying moderate pressure, a line
was slowly drawn with a ballpoint pen about 1–2 cm
from the margin of the skin reaction towards its centre.
When resistance to further movement was felt, the pen
was lifted from the skin. The procedure was repeated
on the opposite side of the skin reaction. This proce-
dure was repeated at right angles, to get a 2-dimen-
sional measurement of the induration. The diameter of
the induration was established by taking the mean of
the distances between the 2 pairs of opposing lines.
Skin reactions with an induration of > 5 mm were
regarded as positive.
The air-dried specimens of finger-prick blood were
stored in plastic bags and sent to the ITM Laboratory.
The DAT was performed as reported elsewhere (Boe-
laert et al., 1999).
To identify the species, a series of blood samples
(180 L) on ethylenediaminetetraacetic acid was taken
from DAT-positive patients admitted to the Huddur
relief centre in 2002. Samples were mixed with the
same volume of AS1-buffer (Qiagen, Hilden, Ger-
many) and sent to ITM. DNA extraction was per-
formed with the QIAamp DNA Blood Mini Kit
according to manufacturer’s instructions (Qiagen).
Characterization of parasites was performed by poly-
merase chain reaction–restriction fragment length poly-
morphism analysis of cysteine proteinase B genes (cpb
PCR–RFLP; K. W. Quispe et al., unpublished data).
A 1079-bp portion of the cpb coding region was ampli-
fied with the following Leishmania-specific primers:
CPBFOR, 59-CGAACTTCGAGCGCAACCT-39 and
CPBREV 59-CAGCCCAGGACCAAAGCAA-39. The
reactions (50 L) contained 20–50 ng DNA, 1 3 final
buffer, 0.5 mM MgCl2, 200 M of deoxyribonucleoside
triphosphate mix, 10 M of each primer and 1.5 U Taq
DNA polymerase (Eurogentec, Seraing, Belgium).
Thermal cycling parameters were: (i) initial denatura-
tion of 5 min at 95 8C, (ii) 35 cycles consisting of
denaturation at 95 8C for 30 s, annealing at 53 8C for 1
min and extension at 72 8C for 1 min, followed by (iii) a
final extension at 72 8C for 10 min. After ethanol
precipitation of DNA, amplicons were cut with restric-
tion enzyme HaeIII, and patterns resolved by electro-
phoresis with the Bioanalyser system (Agilent
Technologies, Meyrin, Switzerland): the latter system
was selected for its high sensitivity and discriminatory
power. DNA from the following reference strains of the
L. donovani complex (obtained from Prof. J.-P. Dedet,
Montpellier, France) was used for characterization of
the field samples: MON-1, MHOM/ES/1993/PM1/
LEM2608; MON-29, MHOM/FR/1996/LEM3249;
MON-2, MHOM/IN/0000/DEVI/LEM138; MON-2,
MHOM/IN/1996/THAK35/LEM3178; MON-30,
MHOM/SD/1982/GILANI; MON-11, MHOM/FR/
1980/LEM189; MON-78, MHOM/MT/1985/BUCK;
and LON-42, MHOM/ET/00/HUSSEN. The un-
cleaved 1079-bp cpb amplicon was not observed with
DNA of Trypanosoma gambiense, Plasmodium falciparum,
and Mycobacterium tuberculosis. The detection threshold
of our PCR was estimated to be between 10
2 and 10
3
parasites=mL blood (healthy human blood seeded with
L. donovani promastigotes).
Results
Clinical case series
Between July 2000 and August 2001, 392 patients
presented to the MSF centre in Huddur with a history
of fever of at least 1 month, splenomegaly and wasting.
In 59% of them (230=392) the DAT was positive, and
they were treated for VL. In 2 of the latter patients, a
spleen aspiration was performed, showing numerous
L. donovani bodies (grade 5 according to WHO clas-
sification; WHO, 1996). The typical clinical presenta-
tion of VL in Huddur was a pale and wasted child aged
, 10 years, with a dry cough and a swollen abdomen,
and complaining of intermittent fever, poor appetite,
and epistaxis (Fig. 2).
A remarkable finding from the history of the patients
was the very long duration of their sickness. In the
period July to December 2000, the average duration of
sickness before presentation to the health facility was
19 months. This average dropped to 9 months in the
period January to August 2001.
Figure 3 shows the age and gender distribution of the
230 VL patients. Only 9 of the 230 patients were aged
. 15 years. The overall gender ratio was M:F ¼ 1.58:1
(n ¼ 229). In the age group 5–10 years the M:F ratio
was 1.2:1 (n ¼ 99).
A minority of the patients had daily fever in the
observation period prior to the start of VL treatment,
but most had intermittent fever. All patients had sple-
nomegaly. The mean spleen size was 11 cm under the
costal margin in the mid-clavicular line (range 3–26
cm). There was no lymphadenopathy in the patients.
Pulmonary infections, including pulmonary TB, were
the most common intercurrent infections. In 215 pa-
tients the weight-for-height at the beginning of the
treatment was registered. In 44% of these the weight-
for-height index was < 80% of the median, the cut-off
for acute wasting. At the end of treatment, the average
weight gain as a percentage of the weight at the start of
treatment was 9.6%. The treatment regimen was well
tolerated. None of the patients receiving SSG had to
have their treatment stopped or interrupted because of
toxic effects, though vomiting was frequent. During the
study period, only 225 patients were actually started on
treatment, while 5 patients died before drug treatment
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treatment extended beyond 30 d. Thirteen of 225 pa-
tients (5.8%) died during the treatment. Case fatality
rates significantly improved with time: in the first 6
months of the programme, the case fatality rate was
9.1% (11=121), in the next 6 months it was only 1.9%
(2=104) (
2 ¼ 5.28, P ¼ 0.02). Anaemia and its conse-
quences were the most frequent causes of death. Spleen
size at the end of the 30 d of treatment was reduced by
25–50% in 40% of the cases. In only 10% of the cases
the spleen was reduced by 75–100%. Contrastingly, in
the north-west of Ethiopia, 90% of treated VL patients
had no palpable spleen at the end of their 30 d of
treatment (M. Marlet, unpublished data).
Only 1 possible post-kala-azar dermal leishmaniasis
case was recognized; a boy who did not improve very
much, was still too weak to walk properly, and devel-
oped a herpes zoster at the end of his treatment. He
was started on TB treatment on clinical grounds. In the
first weeks of the TB treatment he developed a fine
papular rash all over his body, which resolved in about
6 weeks without additional treatment. El-Hassan &
Zijlstra (2001) described similar rashes. Two other pa-
tients presented again with fever and a growing spleen a
few months after they had finished their primary VL
treatment. On clinical grounds they were diagnosed as
relapse cases. Retrospectively, these patients still
showed intermittent fever in the last week of their
primary treatment and they did not get the recom-
mended extension of the VL treatment.
Entomology
The Bakool region is a rather flat area at an altitude
of 550 m above sea level. The vegetation consists of
many Acacia spp. and fewer Balanites spp. The rainy
season of April 2001 lasted only 2 weeks. People grow
maize and sorghum but also have livestock. There are
large numbers of huge termite hills, spread over the
fields, in the bush but also on the compounds of the
people. Apart from many Sergentomyia spp., Phleboto-
mus martini and P. vansomerenae were captured from
termite hills in and around Huddur.
Epidemiological screening
Figure 4 shows the age and gender distribution of
the 161 displaced persons screened. Fifteen percent
(26=161) had a positive LST reaction. LST positivity
was significantly different according to age: only 5%
(4=74) of those aged , 15 years were LST-positive,
compared with 25% (22=87) of those aged > 15 years
(2 ¼ 11.62, P , 0.001). In the latter age group, 51.5%
(17=33) of men were positive compared with 9.3%
(5=54) of women (
2 ¼ 19.36, P , 0.001). Only 3 of
the 161 displaced persons screened had a positive
DAT; they were aged , 10 years and 1 of them had
been recently treated for VL.
Parasite characterization
Parasite genotyping was performed directly (i.e.
without parasite isolation) on 9 blood samples obtained
from patients from Huddur. The cpb PCR–RFLP
patterns of field samples were compared with those of
reference strains representative of the genetic diversity
within the L. donovani complex. After deduction of a
few weak bands corresponding to amplification of hu-
man DNA (see open arrows in Fig. 5), patterns of field
samples were found to be different from Mediterranean
L. infantum (absence of 260-bp diagnostic fragment;
see star in Fig. 5) and Indian L. donovani (absence of
260- and 296-bp fragments; see star in Fig. 5) reference
strains, and most similar to the Sudanese reference
strain of MON-30 and the Ethiopian reference strain of
LON-42 (presence of 6 fragments of 71, 100, 152,
167, 186, and 217 bp; see arrows in Fig. 5).
Discussion
This is the first report of VL in the Bakool region of
south-eastern Somalia. Because of the precarious
health infrastructure and the weak referral capacity,
spleen aspirations were not routinely done in the relief
centre. However, the characteristic symptoms and
signs, the serological evidence and the good response to
antimonial therapy made it quite convincing that we
were dealing with an outbreak of VL. The outbreak was
confirmed by direct microscopical evidence of L. dono-
vani in spleen aspirates obtained from 2 subjects.
Furthermore, molecular characterization performed di-
rectly on blood samples from patients admitted in 2002
confirmed the presence of Leishmania parasites. Para-
site genotyping indicated a close genetic similarity with
a Sudanese reference strain classified as an ancestral
zymodeme of L. infantum (MON-30; Rioux et al.,
1990) and an Ethiopian reference strain of zymodeme
LON-42, classified as L. donovani, but phylogenetically
closest to L. infantum. More precise typification should
be confirmed by further studies, as species delineation
Fig. 2. Four-year-old girl with visceral leishmaniasis in Bakool
region, Somalia.
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Fig. 3. Age and gender distribution of 230 visceral leishmania-
sis patients admitted to a Me ´decins sans Frontie `res centre in
Huddur, Bakool region, Somalia (2000–01).
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Eastern Africa, where the original focus of VL has been
postulated (Pratlong et al., 2001). Information ob-
tained by qualitative methods gave no reason to believe
that VL is a newly emerging problem in the area. The
population of Bakool knows the syndrome of VL and
calls it ‘dedabsi’, meaning ‘big spleen’. Traditional hea-
lers claim to have treated dedabsi as long as they can
remember, though allegedly it may have increased
somehow over the last few years. Apparently, this in-
crease was concurrent with the drought period of 2000
and 2001. Contrastingly, in most of neighbouring
Gedo, Somalia, and in Wajir district, Kenya, the popu-
lation stated not to have known about VL before the
outbreak of 2000–01.
The clinical presentation of VL in Bakool is also
different, compared with the cases observed in Gedo
and Wajir district. The cases seen in Bakool are mainly
paediatric, the disease is protracted and the case fatality
rate is quite low. Though our clinical case series was
observed at what was originally a therapeutic feeding
centre, which attracts mainly children, we are quite
sure few adult VL cases escaped medical attention, as
the centre was the only facility providing medical care
for the whole region. This corroborates findings in the
rapid population assessment carried out in August
2000. Thus, according to its paediatric profile, VL
seems to be endemic in this region, in contrast to VL in
its epidemic form, which affects all age ranges of a
population. Children are probably exposed to the vec-
tor on or near their compounds. Both boys and girls
may get infected, playing around and on top of the
termite hills, the resting places of the vector. They also
may get infected in the early evening or when sleeping
outdoors, which is very common in this region.
We identified both P. martini and P. vansomerenae
among many Sergentomyia spp. Phlebotomus martini is a
proven vector of VL in other foci (Gebre-Michael &
Lane, 1996) and is present throughout the year in the
Konso focus in Ethiopia (Gebre-Michael & Lane,
1996). In Wajir district, Kenya and Konso, Ethiopia,
P. celiae is also present, but mostly in the rainy season.
We were not able to catch sandflies during the very
short rainy season of 2001, and could thus very well
have missed P. celiae sp. With P. martini being the
assumed vector for Bakool, we expect the VL cases to
occur throughout the year, though our observation
period was too short to confirm this assumption. Also,
the presented VL cases were suffering for 3 months
upto 3 years. One reason for this could be that there
were no health facilities in this war-stricken region over
a period of at least 10 years, so cases were not treated
up to July 2000.
To study the frequency of infection, we studied a
purposive sample of the Bakool population: all the
residents of a small camp on the edge of Huddur town,
and all displaced people from other areas of Bakool
region. Men aged 20–40 years were clearly underrepre-
sented in this sample. The displaced had left their
home areas mostly because of drought and famine, and
this may have biased the results, because these circum-
stances may well have influenced both the exposure to
the vector as well as the susceptibility to VL. The
selection of this particular group was made for reasons
of feasibility. In Somalia, insecurity and the nomadic
lifestyle of the population make it very difficult to
survey any community at repeated intervals of 48 h.
Though not representative of the rural population in a
probabilistic way, the results in displaced persons from
the rural areas of Bakool show a high past infection
rate, as indicated by LST positivity. Moreover, this rate
is lower in young persons compared to adults. In
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Fig. 4. Age and gender distribution of 161 displaced persons in Huddur, Bakool region, Somalia (2000–01).
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Fig. 5. Molecular characterization of samples from visceral
leishmaniasis (VL) patients in Huddur compared with refer-
ence strains of the Leishmania donovani complex: polymerase
chain reaction–restriction fragment length polymorphism
analysis of cysteine proteinase B genes after cleavage with
HaeIII and electrophoresis in the bioanalyser system. Lane 1,
size marker; lane 2, DNA from a healthy human; lanes 3–6,
DNA obtained from blood of VL patients; lane 7, MON-30;
lane 8, LON-42; lane 9, MON-78; lane 10, MON-29; lane
11, MON-2; open arrows, fragments encountered in healthy
human blood and deduced from patient samples; closed
arrows, 6 fragments found in East African stocks (MON-30
and LON-32) and in patient samples; stars, fragments found
in L. infantum and Indian L. donovani and absent in patient
samples.
670 M. V. L. MARLET ET AL.adults, past infection rates were significantly higher in
males than in females, which might be related to the
selection bias (only weakest male adults residing in the
camp) or to gender-specific exposure patterns. The
men work in the rather cool mornings and evenings on
their fields and wander day and night through the bush
with their flocks of goats and camels. Assuming that the
seroconversion in DAT precedes the cellular immune
response, none of the adults showed recent infection.
Since their arrival in the camp 4 years ago, they were
dependent on food distribution and probably reduced
their activities on fields and in the bush.
VL seems to be a longstanding and serious health
problem in children in this region. The age distribution
of the VL cases and to a lesser extent, the results of the
serological screening in displaced persons are similar to
the findings of Shiddo et al. (1995) in Middle Shebele
region. The age and gender distribution of cases and of
asymptomatic individuals corresponds to that of an
endemic area. Food insecurity might have increased
the emergence and detection of VL in this remote and
neglected area. Unfortunately, the health problems of
Somalia are not on the international agenda today.
Nevertheless, the health infrastructure and the food
security of this population cannot be eternally ne-
glected.
Acknowledgements
All staff of Me ´decins sans Frontie `res-Belgium in Huddur
are acknowledged for doing a great job caring for the VL
patients under exceptionally difficult conditions. Special
thanks to Dr M. Englebert who initiated the programme in
Huddur. Cooperation with Dr D. Sang (Ministry of Health
Kenya) resulted in the sandfly identification. Molecular char-
acterization was made with the support of an EC-project
(QLK2-CT-2002-01810).
References
Baruffa, G. (1965). Kala-azar among the nomands of the
Middle Webi Shebeli Region; first report of a confirmed
endemic source of kala-azar in Somalia. Transactions of the
Royal Society of Tropical Medicine and Hygiene, 59, 705–708.
Boelaert, M., El Safi, S., Jacquet, D., De Muynck, A., Van der
Stuyft, P. & Le Ray, D. (1999). Operational validation of
the direct agglutination test for diagnosis of visceral leishma-
niasis. American Journal of Tropical Medicine and Hygiene, 60,
129–134.
Boussery, G., Boelaert, M., van Peteghem, J., Ejikon, P. &
Henckaerts, K. (2001). Visceral leishmaniasis (kala-azar)
outbreak in Somali refugees and Kenyan shepherds, Kenya.
Emerging Infectious Diseases, 7, 603–604.
El-Hassan, A. M. & Zijlstra, E. E. (2001). Leishmaniasis in
Sudan. 1. Cutaneous leishmaniasis. Transactions of the Royal
Society of Tropical Medicine and Hygiene, 95, supplement 1,
S1/1–S1/17.
Gebre-Michael, T. & Lane, R. P. (1996). The roles of Phlebo-
tomus martini and P. celiae (Diptera: Phlebotominae) as
vectors of visceral leishmaniasis in the Aba Roba focus,
southern Ethiopia. Medical and Veterinary Entomology, 10,
53-62.
Moise, R. (1955). A proposito dei casi di kala azar finora
segnalati. Annali di Medicina Navale e Tropicale, 68,
481–501.
Penso, G. (1934). Il kala azar nella Somalia Italiana. Bollettini
e Atti di Ricerca Accademia Medica Roma, 60, 292–293.
Pratlong, F., Dereure, J., Bucheton, B., El-Safi, S., Dessein,
A., Lanotte, G. & Dedet, J. P. (2001). Sudan: the possible
original focus of visceral leishmaniasis. Parasitology, 122,
599–605.
Rioux, J. A., Lanotte, G., Serres, E., Pratlong, F., Bastien, P.
& Perieres, J. (1990). Taxonomy of Leishmania, use of
isoenzymes. Suggestions for a new classification. Annales de
Parasitologie Humaine et Compare ´e, 65, 111–125.
Shiddo, S. A., Aden, M. A., Akuffo, H. O., Mohamud, K. A.,
Herzi, A. A., Herzi Mohamed, H., Huldt, G., Nilsson, L.
A., Ouchterlony, O. & Thorstensson, R. (1995). Visceral
leishmaniasis in Somalia: prevalence of markers of infection
and disease manifestations in a village in an endemic area.
Transactions of the Royal Society of Tropical Medicine and
Hygiene, 89, 361–365.
WHO (1984). The Leishmaniases: Report of a WHO Expert
Committee. Geneva: World Health Organization, Technical
Report Series, No. 701.
WHO (1996). Manual on Visceral Leishmaniasis Control. Gene-
va: World Health Organization, WHO/LEISH/96.40.
Woolhead, A. (1995). A recent case of visceral leishmaniasis
in Somalia. Annals of Tropical Medicine and Parasitology, 89,
687–688.
Received 11 February 2003; revised 25 June 2003;
accepted for publication 4 July 2003
VISCERAL LEISHMANIASIS OUTBREAK IN SOMALIA 671